Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rein

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Physical Review Letters|January 20, 2026
Next-to-Leading-Order Corrections and Factorization for Transverse Single-Spin AsymmetriesDaniel Rein, Marc Schlegel, Patrick Tollkühn, et al.
Cancer Reports (Hoboken, N.J.)|June 4, 2021
The rate of estrogen receptor-conversion associated with tumor progression in estrogen receptor-positive breast cancer patients following adjuvant Tamoxifen administrationSirus Djahansouzi, Bettina Hanstein, Daniel Rein, et al.
Gynecologic Oncology|April 15, 2008
New aspects of vulvar cancer: changes in localization and age of onsetMonika Hampl, Stella Deckers-Figiel, Juergen A Hampl, et al.
Cytokine|August 20, 2013
CXCL1 expression in human decidua in vitro is mediated via the MAPK signalling cascadeDunja Maria Baston-Büst, Andrea Schanz, Sarah Jean Böddeker, et al.
Langenbeck'S Archives of Surgery|February 12, 2014
Survey of compartment syndrome of the lower extremity after gynecological operationsEmanuel C A Bauer, Nicolina Koch, Christoph J Erichsen, et al.
Cancer Research|July 18, 2008
Tissue-specific promoters active in CD44+CD24-/low breast cancer cellsGerd J Bauerschmitz, Tuuli Ranki, Lotta Kangasniemi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicityTyler O Kirby, Angel Rivera, Daniel Rein, et al.
Journal of Neurosurgery|April 20, 2006
The human survivin promoter: a novel transcriptional targeting strategy for treatment of gliomaWinan J Van Houdt, Yosef S Haviv, Baogen Lu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Physical Review Letters|January 20, 2026
Next-to-Leading-Order Corrections and Factorization for Transverse Single-Spin AsymmetriesDaniel Rein, Marc Schlegel, Patrick Tollkühn, et al.
Cancer Reports (Hoboken, N.J.)|June 4, 2021
The rate of estrogen receptor-conversion associated with tumor progression in estrogen receptor-positive breast cancer patients following adjuvant Tamoxifen administrationSirus Djahansouzi, Bettina Hanstein, Daniel Rein, et al.
Gynecologic Oncology|April 15, 2008
New aspects of vulvar cancer: changes in localization and age of onsetMonika Hampl, Stella Deckers-Figiel, Juergen A Hampl, et al.
Cytokine|August 20, 2013
CXCL1 expression in human decidua in vitro is mediated via the MAPK signalling cascadeDunja Maria Baston-Büst, Andrea Schanz, Sarah Jean Böddeker, et al.
Langenbeck'S Archives of Surgery|February 12, 2014
Survey of compartment syndrome of the lower extremity after gynecological operationsEmanuel C A Bauer, Nicolina Koch, Christoph J Erichsen, et al.
Cancer Research|July 18, 2008
Tissue-specific promoters active in CD44+CD24-/low breast cancer cellsGerd J Bauerschmitz, Tuuli Ranki, Lotta Kangasniemi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicityTyler O Kirby, Angel Rivera, Daniel Rein, et al.
Journal of Neurosurgery|April 20, 2006
The human survivin promoter: a novel transcriptional targeting strategy for treatment of gliomaWinan J Van Houdt, Yosef S Haviv, Baogen Lu, et al.
Pageof 1